Abstract
We previously reported a case in which steroid-induced psychosis was eliminated with risperidone treatment in a patient with polyarteritis nodosa (PN). In the present report, we longitudinally tracked the serum levels of brain-derived neurotrophic factor (BDNF). We found that corticosteroid lowered serum BDNF levels, and improvement of psychiatric symptoms was intact with the serum BDNF levels seen in the patients.
Highlights
There are several reports demonstrating the effectiveness of risperidone in treating steroid psychosis [1,2]
We have previously demonstrated that risperidone did not change serum brain-derived neurotrophic factor (BDNF) levels in patients with schizophrenia [3]
BDNF is associated with psychiatric diseases such as depression or schizophrenia [1]
Summary
There are several reports demonstrating the effectiveness of risperidone in treating steroid psychosis [1,2]. Introduction There are several reports demonstrating the effectiveness of risperidone in treating steroid psychosis [1,2]. We have previously demonstrated that risperidone did not change serum brain-derived neurotrophic factor (BDNF) levels in patients with schizophrenia [3]. BDNF is associated with psychiatric diseases such as depression or schizophrenia [1].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
